openPR Logo
Press release

Superbugs & Superdrugs USA Conference returns to New Jersey this November

06-07-2018 11:48 AM CET | Health & Medicine

Press release from: SMi Group

Superbugs & Superdrugs USA Conference returns to New Jersey this

SMi Group reports: agenda released for 3rd annual Superbugs & Superdrugs USA conference

Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018.

Antimicrobial resistance, leading to the development of superbugs, is a major threat to public health and continues to increase as a problem, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics, several incentive initiatives have been set up - CARBX, BARDA, IMI (EU) - in order to encourage reinvestments. From a governmental point of view, the challenge lies in encouraging companies to develop new antimicrobial drugs and to strengthen and maintain the pipeline of antibiotics and other antimicrobials currently being developed.

This years' Superbugs & Superdrugs USA Conference programme will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field, making this event the perfect platform to strengthen knowledge in key principles.

Speakers include:
• Anthony Simon Lynch, Senior Scientific Director, Janssen
• William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
• Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
• Mark Albrecht, Project Officer, HHS/ASPR/BARDA
• Antonio DiGiandomenico, Principal Scientist, MedImmune
• Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
• Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
• Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Plus, topical workshops on November 14:
• Rapid diagnostics for drug resistance: Are we there yet?
• Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics

Further details at http://www.superbugs-usa.com/openpr

Twitter - @SMIpharm & #smibugs
LinkedIn - SMi Pharma

CONTACT:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Lyudmyla Durneva
ldurneva@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Superbugs & Superdrugs USA Conference returns to New Jersey this November here

News-ID: 1074032 • Views: 470

More Releases from SMi Group

Six Key Presentations at SMi's Inaugural Robotics & Automation in Pharma Confere …
SMi Group reports: Six key presentations featured at the Robotics & Automation in Pharma Conference in London on 21-22 February 2022 SMi Group are delighted to announce the launch of the inaugural Robotics and Automation in Pharma conference, taking place on 21st and 22nd February 2022 in London, UK. The 2022 conference theme is on the latest developments in the field surrounding the integration of Robotics and Automation into the Pharmaceutical
SMi Launches it’s 6th Annual Conference and Exhibition: Future Armored Vehicle …
Armoured Vehicles Situational Awareness 2022 4th- 5th April 2022, London, United Kingdom http://www.armouredvehicles-sa.com/ Sponsors: Ni-Or Providing the Armoured Vehicle Crew with the Information to Operate in the Complex Modern Battlespace The SMi Group are pleased to present the next annual conference in the sell-out portfolio of Armoured Vehicle events: Future Armoured Vehicles Situational Awareness (FAVSA) 2022, taking place on the 4th - 5th April 2022 in London. Militaries around the world are continuing to evolve
SMi Launches its 9th Annual Pre-Filled Syringes East Coast Conference
After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them. SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA www.pfsamericas.com/openPR1 Sponsors are: SCHOTT, ZEON Exhibitors: Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group Device innovations, connected delivery
Only 6 weeks to go until The Transdermal and Microneedle Delivery Conference
SMi Reports: Time is running out to Register for SM’s inaugural conference: Transdermal and Microneedle Delivery will take place on 24th - 25th January 2022 SMi Group is proud to present the inaugural Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London, UK. The Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in

All 5 Releases


More Releases for Superbugs

Interview with Martin Everett speaker at SMi's Superbugs & Superdrugs Conference
SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi's highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th and 31st March 2020 in London. This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of antibiotic resistance. For interested individuals to attend
Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance. As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. For this reason, the Superbugs & Superdrugs conference, taking
Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Confere …
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicine are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019 (http://www.superbugssuperdrugs.com/openpr). This
W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …
SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,
Antibiotic Drug Experts + Senior Industry Leaders set to Gather at Superbugs USA
SMi Group will open doors in 3 weeks to host the next annual USA Superbugs summit when it returns to Iselin, New Jersey on Nov 13th – 14th. http://www.superbugs-usa.com/opr Following over two decades of expertise in Europe, the USA show will gather senior industry experts to delve deeper into core issues surrounding government funding and initiatives, breakthroughs in drug discovery, strategies to strengthen the antibiotic pipeline and resistance prevention. Highlights will include
Motif Biosciences Unveil Novel Solutions for the Treatment Deadly Superbugs
SMi Group will welcome the expertise of David Huang when he presents exclusive updates on Iclaprim, a novel diaminopyrimidine, for the treatment of serious gram- positive infections, at Superbugs & Superdrugs USA this fall. The talk will explore how Iclaprim addresses an unmet medical need in hospitalized patients with serious and life-threatening infections including MRSA. With over 15 years of clinical, academic, industry, and research experience in medicine and in the